- Financial Times•18 hours ago
When Egypt launched a mass medical programme in the 1970s the intention was to treat people suffering from schistosomiasis, or bilharzia, a parasitic disease that was widespread in the Arab state. But ...
- Motley Fool•19 hours ago
Rich dividend yields at a cheap price? Healthcare stocks AbbVie, Gilead Sciences, and Teva check off both boxes.
- Investor's Business Daily•2 days ago
Gilead will bulk up its HIV and NASH units even as its Hep C drug sales crumble, Needham analyst Alan Carr said Friday.
GILD: Summary for Gilead Sciences, Inc. - Yahoo Finance
Gilead Sciences Inc. (GILD)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
|Bid||70.99 x 5500|
|Ask||71.11 x 1000|
|Day's range||70.58 - 72.00|
|52-week range||70.58 - 103.10|
Trade prices are not sourced from all markets
|PE ratio (TTM)||6.57|
|Dividend & yield||1.88 (2.65%)|
|1y target est||N/A|